The Diagnostic Imaging mammography modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of mammography, including 2D digital mammography, digital breast tomosynthesis, and breast ultrasound.
April 17th 2025
Seniors who had at least one prior screening mammography exam in the five years prior to breast cancer diagnosis were over a third less likely to die from breast cancer, according to new research.
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
43rd Annual Miami Breast Cancer Conference®
March 5-8, 2026
Register Now!
19th Annual New York GU Cancers Congress™
March 13-14, 2026
Register Now!
Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies
View More
(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice
View More
Siemens plans launch of prone biopsy system
September 26th 2006Siemens Medical Solutions will launch its newly acquired MammoTest breast biopsy table at the RSNA meeting. The rights to the system were acquired by Siemens this summer from now-defunct Fischer Imaging in a deal brokered by the Federal Trade Commission. By late November, the company expects that its managers in every country will be versed in the prone stereotactic biopsy unit and ready to begin selling it globally, said Erica Rouleau, national sales director for women’s health at Siemens.
iCAD hatches plan to dominate mammography CAD
September 12th 2006FujiFilm Medical Systems USA has forged a key distribution agreement with iCAD to serve as a supplier of computer-aided detection products for Fuji’s CR mammography. As important as this deal is to Fuji, it may be even more important for iCAD.
Personal contact proves key to increasing mammography compliance
August 17th 2006More mammography facilities closed in the U.S. than opened for business between 2001 and 2004, according to a report by the Government Accountability Office released Aug. 16. The report concludes that current supply is sufficient to meet the demand, but the GAO’s reason is an indictment of U.S. healthcare.
Technology changes drive new x-ray standards
August 16th 2006The National Electrical Manufacturers Association has published two new standards for manufacturers of hard-copy and soft-copy reading devices for full-field digital mammography. The FDA-sanctioned documents should help breast imaging facilities meet their obligations under the Mammography Quality Standards Act.
Google-like system speeds mammography interpretations
August 9th 2006Medical physicists at Duke University are employing an approach similar to the one used by millions of Internet users daily to obtain computer-driven second opinions on mammograms demonstrating suspicious breast masses. The Google-like approach compares questionable mammograms with selected images ranked to reflect the likely value of their information content.
FTC explains pending sale of Fischer assets to Siemens
July 13th 2006Siemens Medical Solutions is poised to enter the prone stereotactic breast biopsy market later this year, as the result of a consent agreement signed last week by Hologic and the Federal Trade Commission regarding assets Hologic purchased last year from Fischer Imaging (DI SCAN 7/10/06, FTC scuttles Hologic purchase of some Fischer Imaging assets).
FTC scuttles Hologic purchase of some Fischer Imaging assets
July 10th 2006The Federal Trade Commission has undone Hologic’s purchase last year of Fischer Imaging’s mammography assets, finding that the acquisition of Fischer’s prone stereotactic breast biopsy systems business harmed U.S. consumers by eliminating Hologic’s only significant U.S. competitor for the sale of this type of product. As part of the FTC settlement, Hologic is required to sell the Fischer prone biopsy assets to Siemens.